NCT05931341

Brief Summary

This study is a clinical trial to observe changes in biomarkers in the blood at pre- and post-supplementation of rosemary extract in healthy adults.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

June 26, 2023

Last Update Submit

November 21, 2023

Conditions

Pharmacokinetics

Outcome Measures

Primary Outcomes (1)

  • Concentration in plasma

    24 hours

Study Arms (3)

Dosage 1

EXPERIMENTAL
Dietary Supplement: Rosemary extract

Dosage 2

EXPERIMENTAL
Dietary Supplement: Rosemary extract

Dosage 3

EXPERIMENTAL
Dietary Supplement: Rosemary extract

Interventions

Rosemary extractDIETARY_SUPPLEMENT

Softgel capsule including rosemary extract

Dosage 1Dosage 2Dosage 3

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy subjects aged between 25 and 55 years
  • Non-smoker
  • Body Mass Index (BMI) between 20 and 30 kg/m2

You may not qualify if:

  • Any history or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, endocrine, metabolic, hematological, neurologic, psychiatric, systemic or infectious disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

rosemary leaf extract

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2023

First Posted

July 5, 2023

Study Start

December 1, 2023

Primary Completion

March 1, 2024

Study Completion

May 1, 2024

Last Updated

November 22, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share